Biomarker

Cadence

Monthly

Latest

2026-10-20

By

Dylan Neel, MD PhD

Based on

12 recent issues

• Covers: Interviews with biotech executives, physicians, and investors on drug development, clinical strategy, and life science innovation.
• For: Biotech founders, pharmaceutical executives, life sciences investors, and research scientists.
• Best for: Professionals and investors navigating the business and science of biopharmaceutical development.
• Skip if: General consumers looking for basic wellness tips or personal medical advice.

Start with

• Parabilis Medicines: Helen Ho: Explores strategic decision-making, partnering, and opportunity assessment in early-stage drug development.
• Lundbeck: Dr. Johan Luthman: Covers the long-term management of neuroscience research and development pipelines.
• RTW: Rod Wong: Discusses fundamental bottom-up biotech investing strategies across preclinical data and clinical trials.

Visit

Summarised by AI from 12 recent issues. Audience size is not included. Prices are not included. Report a mistake.